echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > "Pharmaceutical Headlines" BMS/ Bluebird Multiple Myeloma CAR-T Therapy "World War II" has come to an end.

    "Pharmaceutical Headlines" BMS/ Bluebird Multiple Myeloma CAR-T Therapy "World War II" has come to an end.

    • Last Update: 2020-10-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (2020/09/23) 11 pharmaceutical companies were suspended from production; accidentally found car-T therapy safety weakness breakthrough point originally here; a well-known hospital former director was investigated; 40 more than 1 billion varieties "do not enter and retreat" Yangzijiang, Jichuan and so on who can take the new health insurance ... (Click on the title, available in the original article) (Pharma 1st Time) BMS/Bluebird Bio multiple myeloma CAR-T therapy "World War II" was reviewed by the FDA on September 22nd, BMS and Bluebird Bio announced that the FDA has accepted and granted its biological products license application (BLA) priority review, for research B cell mature resistance The original (BCMA)-oriented chimic antigen recipient (CAR) T-cell immunotherapy idecabtagene vicellel (referred to as ide cel; also known as bb2121) is used to treat adult multiple myeloma (MM) patients who have received at least three treatments, including immunomodulants, protease inhibitors, and anti-CD38 antibodies.
    : The FDA's decision was a turning point.
    (Dandelion) 11 pharmaceutical companies were suspended from production on the 22nd, Anhui Provincial Drug Administration issued two suspension notices, Governor Yan Zheng Chinese medicine tablets Co., Ltd. due to serious defects 1 (part of the batch of Chinese herbal medicine testing in the original records of thin layer chromatography or micro-identification map highly similar test defects), Zhangzhou City Xingrong Chinese Medicine Tablets Co., Ltd. enterprise quality control laboratory can not be effective operation, 2 pharmaceutical companies were suspended production.
    headline: Order a penalty.
    40 more than 1 billion varieties of "no progress, then retreat" Yangzijiang, Jichuan ... Who can take the new health insurance 2020 national health insurance drug catalog adjustment through the form review of the list of declared drugs recently released, 751 products on the list, the number of industry shock: 728 varieties outside the catalog of attention: including 12 new coronary pneumonia diagnosis and treatment program products, 11 base drug products, 28 products that encourage imitation or clinical need, 3 national selected products, and 181 products approved or adaptive after 2015, as well as 493 provincial health insurance catalog products.
    : The bidding phase of the negotiations will take place between October and November.
    "Academic Latitude" accidentally found car-T therapy safety weaknesses breakthrough point originally here? Cell, a leading academic journal, published a research paper on CAR-T immunotherapy online today.
    by scientists in the United States has identified potential causes for a common side effect of the star-studded anti-cancer treatment, and pointed to the direction of improvement.
    : CAR-T therapy is not a one-of-a-pothesity drug.
    the former director of a well-known hospital is under investigation! On September 18, according to the Central Commission for Discipline Inspection and Supervision of the State Supervision Committee in the Ministry of Transport, Hebei Provincial Commission for Discipline Inspection and Supervision news: Civil Aviation Administration Civil Aviation Medical Center (Civil Aviation General Hospital) of the former deputy secretary of the Party Committee, director (president) Li Songlin suspected of serious disciplinary violations, is currently receiving the Central Commission for Discipline Inspection in the Ministry of Transport discipline inspection and supervision of the disciplinary inspection team and hebei Province, Yantai City Commission for Discipline Inspection supervision and investigation.
    : should be investigated in accordance with the law.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.